Work

BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278

Year: 2026

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1016/j.jpet.2026.105011

Authors: Isabelle Cote, Aurore C. Valfort, Ryan K. Sanders, Sheryl L. Burris, Matthew E. Hayes, Rhea Arya, Lingaiah Maram, Bahaa Elgendy, Feng Yue, Thomas P. Burris

Institutions: University of Florida, University of Health Sciences and Pharmacy, Washington University in St. Louis, Institute of Food and Agricultural Sciences

Language: English

Topic: Muscle Physiology and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Sucampo Pharmaceuticals

OpenAlex ID: W7203622517

FWCI:

Cites: 32

Cited by:

Related to: